How to Buy Emergent Biosolutions Stock
Emergent Biosolutions Inc
Emergent Biosolutions is a pharmaceutical company located in Maryland, United States, which is part of the Healthcare sector, and is traded under the ticker EBS on the NYSE exchange.
Emergent Biosolutions stock last closed at $1.92, down 1.54% from the previous day, and has decreased 78.64% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.72 percentage points. Emergent Biosolutions stock is currently +35.21% from its 52-week low of $1.42, and -82.35% from its 52-week high of $10.88.
As of Apr 26, 2024, there are 52.2M EBS shares outstanding. The market value of EBS is $100.23M. In the past 24 hours, 865,620 EBS shares were traded.
How to Buy Emergent Biosolutions Stock
Wondering how to invest in Emergent Biosolutions stock? Here's how.
- Figure out where to buy Emergent Biosolutions stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you determine where to buy Emergent Biosolutions stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your method of payment and add your details.
- Evaluate Emergent Biosolutions stock: The Emergent Biosolutions ticker symbol is EBS. Is Emergent Biosolutions stock a good investment? Should you buy shares of EBS? How do EBS's underlying business fundamentals look? Do top analysts think Emergent Biosolutions is a good buy? Why has EBS's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if EBS is a good stock to buy).
- Place your EBS purchase: Decide if you will purchase EBS shares at the current market price or use a limit order to purchase EBS shares at a given price.
- Watch your investment in EBS: Create a watchlist to get live updates on your new investment in Emergent Biosolutions shares.
Step 1: Figure out where to buy Emergent Biosolutions stock
You will need a brokerage account in order to access the NYSE market and buy EBS stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Tech to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal information so you are able to invest in EBS today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create a new brokerage account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on the best stock trading app for beginners, your next step is to transfer the money for your investment:
Watch the walkthrough below for more details transferring money into your new brokerage account.
Step 4: Evaluate Emergent Biosolutions stock
After you have decided on the best place to buy Emergent Biosolutions stock, it's absolutely critical to research their stock before you buy, so you actually wrap your head around the risk and opportunity.
Emergent Biosolutions shares quick numbers
Fundamentals of EBS
WallStreetZen was built to help part-time investors perform better fundamental analysis.
You can view all of the due diligence checks on EBS's stock page.
Is EBS stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge EBS's true value.
Using relative valuations measures:
- EBS may be undervalued based on its P/B ratio of 0.15x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.09x
You can access additional valuation research on EBS's stock here.
EBS Financial Overview
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the EBS balance sheet.
- There are more short-term assets than long-term liabilities on the EBS balance sheet.
- EBS has $111.70M in cash and short term investments. This is sufficient to cover its annual cash burn of $257.90M.
Failed Health Checks:
- EBS profit margin has gone down from -18.9% to -72.5% in the past year.
- EBS has cash burn of 257900000. It does not have sufficient cash and short-term investments to cover this.
- EBS has a relatively high debt to equity ratio of 1.81.
- Total EBS debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy EBS stock, according to analysts?
Out of 1 Equities analysts who give forecasts on EBS, the consensus analyst rating on Emergent Biosolutions is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Emergent Biosolutions stock forecast page.
EBS Technical Indicators
EBS Growth Numbers
Last year, EBS revenue was $1.05B. Over the last 5 year, EBS's revenue has gone up by 6.05% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.65%.
You can analyze EBS's earnings and revenue performance here.
Latest Insiders Trades at EBS
In the last year, executives and large shareholders at EBS have sold more shares than they have bought.
Coleen Glessner, EVP Quality Ethics and CPL of EBS, was the latest EBS insider to sell. They sold $1,339.65 worth of EBS stock on Apr 7, 2024.
Get more info about who owns EBS shares here.
Does EBS provide a stable income stream?
No, Emergent Biosolutions doesn't provide an income stream by paying out dividends.
EBS Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your EBS purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given price limit, use a limit order.
Click the Open Trade button and your broker will execute your order.
If you want additional assistance investing in stocks on eToro, watch the how to video below:
Step 6: Watch your investment in EBS
Now that you own some EBS shares, you'll want to keep up with your investment.
Start a watchlist to track the latest developments regarding your EBS stock.
EBS Feed
How to Buy Stock in Emergent Biosolutions
To reiterate, here are the 6 steps for buying Emergent Biosolutions stock:
- Figure out where to buy Emergent Biosolutions stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Evaluate Emergent Biosolutions stock
- Place your EBS purchase
- Watch your investment in EBS
If you are looking for a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to track your new investment in Emergent Biosolutions, add EBS to your watchlist by clicking the button below.
More Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.